These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [The use of microcrystal paraffin in the preparation of ointments. 3. Study of the induration inhibiting action of ESMA-P]. Erös I; Kedvessy G Acta Pharm Hung; 1972; 42(3):135-40. PubMed ID: 5026193 [No Abstract] [Full Text] [Related]
25. [Determination of metallic particles in ophthalmic ointments]. Cavatorta L; Romaniello E; Allievi R Boll Chim Farm; 1968 Nov; 107(11):721-5. PubMed ID: 5729799 [No Abstract] [Full Text] [Related]
26. [Quality of various mass-produced and for-storage-prepared ointments. II. Determination of ointment ingredients using thin-layer]. Sarsúnová M Cesk Farm; 1973 Jul; 22(6):259-65. PubMed ID: 4732553 [No Abstract] [Full Text] [Related]
27. [Contact allergy from substances in salves and such]. Tidsskr Nor Laegeforen; 1968 Oct; 88(19):1762-3. PubMed ID: 5700516 [No Abstract] [Full Text] [Related]
28. [Method for study of drug liberation capacity from ointments]. Sallai J; Mayer A Pharmazie; 1969 Aug; 24(8):464-5. PubMed ID: 5345457 [No Abstract] [Full Text] [Related]
29. Quantitative determination of phenol in ointments. Gupta VD; Chan SH Am J Hosp Pharm; 1975 May; 32(5):522-3. PubMed ID: 1146823 [TBL] [Abstract][Full Text] [Related]
30. [Choice of an excipient for pomades]. Marilier M Farmaco Prat; 1969 Feb; 24(2):73-83. PubMed ID: 5780182 [No Abstract] [Full Text] [Related]
31. [Saccharose esters as new auxiliary substances in pharmacy. 3. Their use in ointment bases]. Gruntová Z; Mandák M; Ducková K Cesk Farm; 1967 Jul; 16(6):263-8. PubMed ID: 6056214 [No Abstract] [Full Text] [Related]
32. [Is there a demand for extemporaneously made hydrocortisone ointments?]. Eklund LH; Halldén L; Juhlin L Lakartidningen; 1974 Apr; 71(15):1476-8. PubMed ID: 4826665 [No Abstract] [Full Text] [Related]
33. [Aminocaoline complexes and the possibility of their use in pharmaceutical and medical practice]. Lekhan AS; Bashura GS; Salo DP Farm Zh; 1968; 23(5):61-5. PubMed ID: 5721777 [No Abstract] [Full Text] [Related]
35. [In vitro study of the dynamics of methyluracil release from dosage forms with a collagen base]. Batasheva EV Farmatsiia; 1977; 26(4):50-1. PubMed ID: 902800 [No Abstract] [Full Text] [Related]
36. Studies on the release of solubilized drugs from ointment bases. Part 6: Influence of the volume of the disperse phase and concentration of the drug on liberation from w/o emulsifying ointments. Kubis A Pharmazie; 1982 Nov; 37(11):781-3. PubMed ID: 7163362 [No Abstract] [Full Text] [Related]
37. [Study of ointment bases suitable for the preparation of oxytetracycline ointment]. Wasiak H; Keresztes A Acta Pharm Hung; 1969 May; 39(3):110-6. PubMed ID: 5793292 [No Abstract] [Full Text] [Related]
38. [Determination of amphomycin and neomycin in ointment bases]. Jastalska D; Dzierzyńska I Acta Pol Pharm; 1969; 26(1):57-61. PubMed ID: 5782221 [No Abstract] [Full Text] [Related]
39. Stability studies on hamycin in different ointment bases. Trivedi BM; Rajmane SA Hindustan Antibiot Bull; 1968; 10(4):303-10. PubMed ID: 5690927 [No Abstract] [Full Text] [Related]
40. [Hapten material for use in patch tests (author's transl)]. Fabbri P; Sertoli A; Spallanzani P Med Lav; 1980; 71(1):17-20. PubMed ID: 7453638 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]